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ABSTRACT 26 
Silver-containing phosphate-based glasses were found to reduce the growth of 27 
Pseudomonas aeruginosa and Staphylococcus aureus biofilms that are leading causes of 28 
nosocomial infections. The rate of glass degradation (1.27-1.41 µg.mm
-2
. h
-1
) and the 29 
corresponding silver release was found to account for the variation in its biofilm growth 30 
inhibitory effect.  31 
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Many of the hospital-acquired infections caused by Pseudomonas aeruginosa and 51 
Staphylococcus aureus (6-9, 11, 17) are associated with biofilms and result in 52 
significant morbidity and mortality. Biofilm-associated
 
bacteria show a decreased 53 
susceptibility to antibiotics (4), disinfectants (13) and clearance by host defences (7, 54 
16). Hence, the development of alternative strategies to combat biofilm-associated 55 
infections such as controlled metal ion releasing phosphate-based glasses (PBGs) is of 56 
considerable interest (10, 19). Silver cations exhibit broad antimicrobial
 
activity at 57 
low concentrations, and they are already being used
 
for the treatment of burn wounds 58 
(14) and traumatic injuries (3). Ahmed et al. (1, 2) have shown that PBGs containing 59 
silver in its +1 oxidation state exert antibacterial effects against planktonic P. 60 
aeruginosa and S. aureus. Valappil et al (19) reported that 10, 15 and 20 mol% silver 61 
in PBGs was useful in preventing the growth of S. aureus biofilms. However, striking 62 
a balance between antimicrobial and cyto/biocompatibility is of major importance for 63 
the in vivo clinical application of these PBGs. Therefore the aim of this study was to 64 
prepare low concentration (3 and 5mol% silver) silver-doped PBGs and evaluate their 65 
efficacy against biofilms of P. aeruginosa and S. aureus. 66 
PBGs for this study were produced using NaH2PO4 (BDH), P2O5 (Sigma), and CaCO3 67 
(BDH) as described previously
 
(19) and samples of composition 68 
(P2O5)50(CaO)30(Na2O)20  (denoted Ag0) without silver were also prepared. Ag2SO4 69 
(BDH) was also used for the preparation of silver-doped PBGs, of general 70 
composition (P2O5)50(CaO)30(Na2O)20-x (Ag2SO4)x, where x = 3 and 5, hereafter given 71 
the abbreviations Ag3 and Ag5 respectively. Degradation was studied by measuring 72 
weight loss and ion release was monitored using ion chromatography (IC). Similarly, 73 
Ag
+
 release was measured using a test kit (Merck, UK) described in detail elsewhere 74 
(19). The degradation rates obtained, by applying a line of best fit through the weight 75 
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loss per unit area of each glass against time (data not shown), for the Ag0, Ag3 and 76 
Ag5 glasses were 1.41, 1.27 and 0.83 µg.mm
-2
.h
-1
, respectively. The degradation 77 
profiles of the glasses showed a decrease in degradation rate with an increase in silver 78 
content (Fig. 1). As expected, the highest levels of Ca
2+
 and Na
+
 release were 79 
observed for the composition with the highest dissolution rate, Ag0.  Ag
+
, Na
+
 and 80 
Ca
2+
 release profiles showed a decrease with increasing silver content from Ag3 to 81 
Ag5 (Fig. 1). Among the anions (PO4
3-
, P2O7
4-
, P3O9
3-
 and P3O10
5-
), P3O9
3-
 was the 82 
anion released to the greatest extent, but there were no significant differences between 83 
Ag3 and Ag5 (Fig. 1).  84 
 85 
Biofilm growth and inhibition studies were performed in a constant depth film 86 
fermentor (CDFF; University College Cardiff, Cardiff, UK), described previously 87 
(12)  Viable counts (colony forming units; CFUs) were carried out as described 88 
previously (19) with MacConkey and nutrient agar plates to grow P. aeruginosa and 89 
S. aureus respectively. Statistical analyses of the data and t-test were conducted using 90 
GraphPad Software; San Diego, USA. The initial surface attachment of P. aeruginosa 91 
and S. aureus on silver-doped PBGs was analysed using SEM as described previously 92 
(19) and showed reduced attachment of S. aureus and P. aeruginosa biofilms to Ag3 93 
and Ag5 compared to Ag0 and hydroxyapatite (HA) discs (data not shown). These 94 
results emphasize the need to explore the anti-adhesive properties of silver which 95 
could widen the applications of silver-containing antibacterial formulations, e.g. 96 
coating
 
of catheters with silver ions to avoid bloodstream infections (5, 18). Confocal 97 
laser scanning microscopic (CLSM) analyses were also conducted and the results 98 
showed that the numbers of non-viable bacteria in biofilms were higher for Ag3 and 99 
Ag5 compared to Ag0 glasses (data not shown).  100 
 5 
P. aeruginosa biofilms on Ag3 glasses showed a significant difference (p=0.007) in 101 
the log10 of the viable count at 6h compared to controls (p=0.012) (Fig. 2A) which 102 
became more apparent at 12h (p=0.0001). At 24h, the log10 of the mean number of 103 
viable cells on the Ag3 started to recover from the previous low at 12h, but was still 104 
less than both controls (p≤0.001). At 48h and 120 h, Ag3 continued to show fewer 105 
CFUs compared to controls (p≤0.01). Ag5 glasses showed no significant difference in 106 
the log10 of the viable count compared to Ag0 (p=0.12) and HA (p =0.09) at 6h (Fig. 107 
2B) but there was a significant difference (p≤0.0001) at 12h. At 24h the log10 of the 108 
viable count on Ag5 glasses started to recover from the previous low at 12h, but was 109 
still less than both controls (p≤0.0002). This effect was continued at time points 48 110 
and 120 h since Ag5 glasses showed fewer CFUs compared to controls (p≤0.025). 111 
 112 
S. aureus  biofilms on Ag3 glasses showed a significant difference in the log10 of the 113 
viable count compared to the Ag0 glasses (p≤0.022) but not to HA (p =0.0965) at 6h 114 
(Fig. 3A). At 24h the difference in the log10 of the viable count increased compared to 115 
both controls, Ag0 (p=0.0001) and HA (p =0.0003). However, at 48h, the log10 of the 116 
viable count on the Ag3 glasses started to recover from the previous low at 24h, but 117 
was still less than both controls, (p≤0.0002). At time points 120, and 144 h, the Ag3 118 
glasses continued to show fewer CFUs compared to the Ag0 (p≤0.038) but not to HA 119 
discs (p≤0.0973). Ag5 glasses showed no significant difference in the log10 of the 120 
viable count compared to both Ag0 and HA discs (p≤ 0.492) at 6h (Fig. 3B) but the 121 
difference became apparent at 24h (p≤0.0001). At 48h, the log10 of the viable count on 122 
the Ag5 glasses started to recover from the previous low at 24h, but was still less than 123 
both controls, (p≤0.0015). This effect was maintained until 144 h, as the Ag5 glasses 124 
 6 
continued to maintain a CFU reduction of approximately 1.15 log10 compared to Ag0 125 
and HA (p≤0.014). 126 
 127 
Ag3 and Ag5 glasses were more effective at reducing S. aureus biofilm growth at 128 
24h (1.73 and 2.10 reduction in log10 of the viable count compared to silver-free 129 
glasses) than the Ag20 glass (1.34 reduction in log10 of the viable count compared to 130 
silver-free glasses) reported previously (19). These effects might be due to the higher 131 
glass degradation rates (1.27 and 1.41µg.mm
-2
. h
-1
 respectively for Ag3 and Ag5) and 132 
subsequent silver release (0.116 and 0.188 ppm h
-1
 respectively for Ag3 and Ag5) 133 
achieved for these glasses compared to Ag20 (glass degradation rate of 0.42 µg.mm
-
134 
2
.h
-1
and silver release rate of 0.064 ppm h
-1
) reported previously (19). Thus both Ag3 135 
and Ag5 release sufficient quantities of Ag
+
 to reduce the growth of P. aeruginosa 136 
and S. aureus biofilms but are well within the acceptable cyto/biocompatible range. It 137 
has been reported that the minimum bactericidal concentration of silver is 0.1 ppm, 138 
and the cytotoxic concentration is 1.6 ppm for human cells (15). The ion release 139 
profile confirmed that the Ag
+
 release was within the limits specified above,  0.116 140 
ppm h
-1
 for the Ag3  and 0.188 ppm h
-1
 for the Ag5 compositions. This study on the 141 
ability of Ag
+
 to reduce bacterial adhesion and to reduce biofilm growth is important 142 
for devising novel and efficient strategies to combat infections caused by P. 143 
aeruginosa and S. aureus  biofilms. 144 
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FIGURE LEGENDS 224 
FIG. 1. Relationship between cation and anion release rates, and rate of degradation 225 
of silver-doped PBGs as a function of silver content. 226 
FIG. 2. (A). Log10 CFU/mm
2
 of P. aeruginosa in biofilms formed on  HA, Ag0 and 227 
Ag3 (B) Log10 CFU/mm
2
 of P. aeruginosa in biofilms formed on HA, Ag0 and Ag5 228 
glasses. 229 
FIG.  3. (A). Log10 CFU/mm
2
 of S. aureus in biofilms formed on  HA, Ag0 and Ag3 230 
(B) Log10 CFU/mm
2
 of S. aureus in biofilms formed on HA, Ag0 and Ag5 glasses. 231 
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